Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre

por Gould, Victoria M. W., Francis, James N., Anderson, Katie J., Georges, Bertrand, Cope, Alethea V., Tregoning, John S.
Publicado 2017

2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine

por Tasker, Sybil, Krishnan, Vyjayanthi, Bart, Stephan, Suyundikov, Anvar, Booth, Peta-Gay, Wight O’Rourke, Anna, Zhang, Jianfeng, Georges, Bertrand, Roberts, Scot
Publicado 2018

Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans

por Watson, Jeannette M, Francis, James N, Mesens, Sofie, Faiman, Gabriel A, Makin, Jill, Patriarca, Peter, Treanor, John J, Georges, Bertrand, Bunce, Campbell J
Publicado 2015

Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial

por Tasker, Sybil, Wight O’Rourke, Anna, Suyundikov, Anvar, Jackson Booth, Peta-Gay, Bart, Stephan, Krishnan, Vyjayanthi, Zhang, Jianfeng, Anderson, Katie J., Georges, Bertrand, Roberts, M. Scot
Publicado 2021

The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model

por Dickson, Alexandria, Geerling, Elizabeth, Stone, E. Taylor, Hassert, Mariah, Steffen, Tara L., Makkena, Taneesh, Smither, Madeleine, Schwetye, Katherine E., Zhang, Jianfeng, Georges, Bertrand, Roberts, M. Scot, Suschak, John J., Pinto, Amelia K., Brien, James D.
Publicado 2023

A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts

por Schultz, Michael D., Suschak, John J., Botta, Davide, Silva-Sanchez, Aaron, King, R. Glenn, Detchemendy, Thomas W., Meshram, Chetan D., Foote, Jeremy B., Zhou, Fen, Tipper, Jennifer L., Zhang, Jianfeng, Harrod, Kevin S., Leal, Sixto M., Randall, Troy D., Roberts, M. Scot, Georges, Bertrand, Lund, Frances E.
Publicado 2022

Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge

por King, R. Glenn, Silva-Sanchez, Aaron, Peel, Jessica N., Botta, Davide, Dickson, Alexandria M., Pinto, Amelia K., Meza-Perez, Selene, Allie, S. Rameeza, Schultz, Michael D., Liu, Mingyong, Bradley, John E., Qiu, Shihong, Yang, Guang, Zhou, Fen, Zumaquero, Esther, Simpler, Thomas S., Mousseau, Betty, Killian, John T., Dean, Brittany, Shang, Qiao, Tipper, Jennifer L., Risley, Christopher A., Harrod, Kevin S., Feng, Tsungwei, Lee, Young, Shiberu, Bethlehem, Krishnan, Vyjayanthi, Peguillet, Isabelle, Zhang, Jianfeng, Green, Todd J., Randall, Troy D., Suschak, John J., Georges, Bertrand, Brien, James D., Lund, Frances E., Roberts, M. Scot
Publicado 2021